STOCK TITAN

Replimune to Present at Two Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Replimune Group, Inc. (NASDAQ: REPL) Announces Participation in BTIG Virtual Biotechnology Conference 2023 and Wedbush PacGrow Healthcare Conference 2023
Positive
  • None.
Negative
  • None.

WOBURN, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of a novel portfolio of tumor-directed oncolytic immunotherapies, today announced that members from the Replimune management team will present and host investor meetings at the following two conferences:

BTIG Virtual Biotechnology Conference 2023
Date: Tuesday, August 8, 2023
Fireside Chat Time: 1:30 pm EDT

2023 Wedbush PacGrow Healthcare Conference
Date: Wednesday, August 9, 2023
Location: Lotte Palace Hotel, New York, NY
In-person 1x1 investor meetings only

About Replimune
Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of novel tumor-directed oncolytic immunotherapies. Replimune’s proprietary RPx platform is based on a potent HSV-1 backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The RPx platform has a unique dual local and systemic mechanism of action consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response. This MOA is expected to be synergistic with most established and experimental cancer treatment modalities, and, with an attractive safety profile the RPx platform has the versatility to be developed alone or combined with a variety of other treatment options. For more information, please visit www.replimune.com.

Investor Inquiries
Chris Brinzey
ICR Westwicke
339.970.2843
chris.brinzey@westwicke.com

Media Inquiries
Arleen Goldenberg
Replimune
917.548.1582
media@replimune.com

 


FAQ

What conferences is Replimune Group, Inc. participating in?

Replimune Group, Inc. is participating in the BTIG Virtual Biotechnology Conference 2023 and the Wedbush PacGrow Healthcare Conference 2023.

When and where are the conferences taking place?

The BTIG Virtual Biotechnology Conference 2023 will take place on Tuesday, August 8, 2023, and the Wedbush PacGrow Healthcare Conference 2023 will be held on Wednesday, August 9, 2023, at the Lotte Palace Hotel in New York, NY.

What is the schedule for Replimune's participation in the conferences?

Replimune will host a fireside chat at 1:30 pm EDT during the BTIG Virtual Biotechnology Conference 2023 and will hold in-person 1x1 investor meetings at the Wedbush PacGrow Healthcare Conference 2023.

Replimune Group, Inc.

NASDAQ:REPL

REPL Rankings

REPL Latest News

REPL Stock Data

755.67M
64.01M
4.74%
103.57%
10.32%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
WOBURN